The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Key role of mast cells and their major secretory products in inflammatory bowel disease
Open accessAbstract
Historically, mast cells were known as a key cell type involved in type I hypersensitivity. Until last two decades, this cell type was recognized to be widely involved in a number of non-allergic diseases including inflammatory bowel disease (IBD). Markedly increased numbers of mast cells were observed in the mucosa of the ileum and colon of patients with IBD, which was accompanied by great changes of the content in mast cells such as dramatically increased expression of TNFalpha, IL-16 and substance P. The evidence of mast cell degranulation was found in the wall of intestine from patients with IBD with immunohistochemistry technique. The highly elevated histamine and tryptase levels were detected in mucosa of patients with IBD, strongly suggesting that mast cell degranulation is involved in the pathogenesis of IBD. However, little is known of the actions of histamine, tryptase, chymase and carboxypeptidase in IBD. Over the last decade, heparin has been used to treat IBD in clinical practice. The low molecular weight heparin (LMWH) was effective as adjuvant therapy, and the patients showed good clinical and laboratory response with no serious adverse effects. The roles of PGD2, LTC4, PAF and mast cell cytokines in IBD were also discussed. Recently, a series of experiments with dispersed colon mast cells suggested there should be at least two pathways in man for mast cells to amplify their own activation-degranulation signals in an autocrine or paracrine manner. The hypothesis is that mast cell secretogogues induce mast cell degranulation, release histamine, then stimulate the adjacent mast cells or positively feedback to further stimulate its host mast cells through H1 receptor. Whereas released tryptase acts similarly to histamine, but activates mast cells through its receptor PAR-2. The connections between current anti-IBD therapies or potential therapies for IBD with mast cells were discussed, implicating further that mast cell is a key cell type that is involved in the pathogenesis of IBD. In conclusion, while pathogenesis of IBD remains unclear, the key role of mast cells in this group of diseases demonstrated in the current review implicates strongly that IBD is a mast cell associated disease. Therefore, close attentions should be paid to the role of mast cells in IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two types of human mast cells that have distinct neutral protease compositions.
Irani, A. A., Schechter, N. M., Craig, S. S., DeBlois, G., & Schwartz, L. B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4464 · Cited by 1,005
Interleukin-10 Therapy—Review of a New Approach
Asadullah, K., Sterry, W., & Volk, H. D. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.4 · Cited by 946
Kovanen, P. T., Kaartinen, M., & Paavonen, T. (1995) · Circulation · doi:10.1161/01.cir.92.5.1084 · Cited by 613
Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2
Molino, M., Barnathan, E. S., Numerof, R., Clark, J., Dreyer, M., Cumashi, A., Hoxie, J. A., Schechter, N., Woolkalis, M., & Brass, L. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4043 · Cited by 591
The incidence and management of infusion reactions to infliximab: a large center experience
Cheifetz, A. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00231-4 · Cited by 491
Induction of Intestinal Inflammation in Mouse by Activation of Proteinase-Activated Receptor-2
Cenac, N., Coelho, A.-M., Nguyen, C., Compton, S., Andrade-Gordon, P., MacNaughton, W. K., Wallace, J. L., Hollenberg, M. D., Bunnett, N. W., Garcia-Villar, R., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64466-5 · Cited by 378
Cairns, J. A., & Walls, A. F. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.275 · Cited by 344
Laine, P., Kaartinen, M., Penttilä, A., Panula, P., Paavonen, T., & Kovanen, P. T. (1999) · Circulation · doi:10.1161/01.cir.99.3.361 · Cited by 342
Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat
Santos, J., Yang, P.-C., Söderholm, J. D., Benjamin, M., & Perdue, M. H. (2001) · Gut · doi:10.1136/gut.48.5.630 · Cited by 313
Crohn's disease: Transmission electron microscopic studies
Dvorak, A. M., Monahan, R. A., Osage, J. E., & Dickersin, G. R. (1980) · Human Pathology · doi:10.1016/s0046-8177(80)80072-4 · Cited by 298
Cited by
Interleukin-1 (IL-1): A central regulator of stress responses
Goshen, I., & Yirmiya, R. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.10.001 · Cited by 399
Regulation of the immune response and inflammation by histamine and histamine receptors
O’Mahony, L., Akdis, M., & Akdis, C. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.06.051 · Cited by 313
The role of mast cells in functional GI disorders
Wouters, M. M., Vicario, M., & Santos, J. (2016) · Gut · doi:10.1136/gutjnl-2015-309151 · Cited by 308
Keita, Å. V., & Söderholm, J. D. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01498.x · Cited by 286
Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors
Kurashima, Y., Amiya, T., Nochi, T., Fujisawa, K., Haraguchi, T., Iba, H., Tsutsui, H., Sato, S., Nakajima, S., Iijima, H., et al. (2012) · Nature Communications · doi:10.1038/ncomms2023 · Cited by 286
Advances in mast cell biology: new understanding of heterogeneity and function
Moon, T. C., St Laurent, C. D., Morris, K. E., Marcet, C., Yoshimura, T., Sekar, Y., & Befus, A. D. (2010) · Mucosal Immunology · doi:10.1038/mi.2009.136 · Cited by 274
Serine proteases of the human immune system in health and disease
Heutinck, K. M., ten Berge, I. J. M., Hack, C. E., Hamann, J., & Rowshani, A. T. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.04.020 · Cited by 262
Mast cell activation syndrome: A newly recognized disorder with systemic clinical manifestations
Hamilton, M. J., Hornick, J. L., Akin, C., Castells, M. C., & Greenberger, N. J. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.04.037 · Cited by 132
“Stomach 7 17 (13) 14-28 (5-21) Duodenum 7 23 (27) 18-26 (4-51) Left colon 5 20 (21) 15-27 (10-31) Right colon 4 17 (21) 12-18 (10-31)”
Mast cells and nerves tickle in the tummy
Rijnierse, A., Nijkamp, F. P., & Kraneveld, A. D. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.008 · Cited by 105
The bidirectional communication between neurons and mast cells within the gastrointestinal tract
Van Nassauw, L., Adriaensen, D., & Timmermans, J.-P. (2007) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.10.003 · Cited by 99
Kiyokawa, H., Abe, M., Matsui, T., Kurashige, M., Ohshima, K., Tahara, S., Nojima, S., Ogino, T., Sekido, Y., Mizushima, T., et al. (2022) · The American Journal of Pathology · doi:10.1016/j.ajpath.2022.03.006 · Cited by 32
Gatti, S., Gelzoni, G., Catassi, G. N., & Catassi, C. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.742830 · Cited by 14
Metadata
- Authors
- He, S.-H.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2004
- Volume
- 10
- Issue
- 3
- Pages
- 309
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W65678198
- Cited by
- 263
- References
- 144
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.